Funding · Company
Hemanext Inc.
Lexington, MABiotech & Pharma
Hemanext Inc. of Lexington, MA has disclosed $61M across 2 Form D offerings filed with the SEC between Oct 15, 2021 and Jul 31, 2025.
$61M
Total disclosed
2
Form D offerings
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$40M
Form D · Oct 15, 2021 ↗
Q4 2021
· target $59M
Filing details
HeadquartersLexington, MAIndustryBiotech & Pharma (Biotechnology)SEC CIK0001305849Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →